Granules India Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Granules India Limited with three other
companies in this sector in India:
Natco Pharma Limited
sales of 11.42 billion Indian Rupees [US$171.24 million]
of which 75%
was Finished Dosage Formulations),
Aarti Drugs Limited
(11.35 billion Indian Rupees [US$170.23 million]
Nectar Lifesciences Limited
(16.76 billion Indian Rupees [US$251.37 million]
of which 100%
was Bulk drugs).
During the year ended March of 2016, sales at
Granules India Limited were 14.30 billion Indian Rupees (US$214.56 million).
increase of 10.8%
versus 2015, when the company's sales were 12.91 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Granules India Limited
(and since 2011, sales have increased a total of 201%).